이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Emami 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Harsha Agarwal

최고 경영자

₹61.8m

총 보상

CEO 급여 비율	42.7%
CEO 임기	2.3yrs
CEO 소유권	0.1%
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	17yrs

최근 관리 업데이트

Recent updates

CEO 보상 분석

Harsha Agarwal 의 보수는 Emami 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Mar 31 2024	n/a	n/a	₹7b
Dec 31 2023	n/a	n/a	₹7b
Sep 30 2023	n/a	n/a	₹7b
Jun 30 2023	n/a	n/a	₹7b
Mar 31 2023	₹62m	₹26m	₹6b
Dec 31 2022	n/a	n/a	₹9b
Sep 30 2022	n/a	n/a	₹8b
Jun 30 2022	n/a	n/a	₹8b
Mar 31 2022	₹13m	₹12m	₹8b
Dec 31 2021	n/a	n/a	₹6b
Sep 30 2021	n/a	n/a	₹6b
Jun 30 2021	n/a	n/a	₹5b
Mar 31 2021	₹12m	₹11m	₹5b
Dec 31 2020	n/a	n/a	₹4b
Sep 30 2020	n/a	n/a	₹3b
Jun 30 2020	n/a	n/a	₹3b
Mar 31 2020	₹12m	₹11m	₹3b
Dec 31 2019	n/a	n/a	₹3b
Sep 30 2019	n/a	n/a	₹3b
Jun 30 2019	n/a	n/a	₹3b
Mar 31 2019	₹11m	₹10m	₹3b
Dec 31 2018	n/a	n/a	₹3b
Sep 30 2018	n/a	n/a	₹3b
Jun 30 2018	n/a	n/a	₹3b
Mar 31 2018	₹8m	₹7m	₹3b

보상 대 시장: Harsha 의 총 보상 ($USD 740.58K )은 Indian 시장( $USD 544.21K ).

보상과 수익: Harsha 의 보상은 지난 1년 동안 20% 이상 증가했습니다.

CEO

Harsha Agarwal (48 yo)

2.3yrs

테뉴어

₹61,808,000

보상

Mr. Harsha Vardhan Agarwal, B.Com., serves as Vice Chairman and Managing Director of Emami Limited since April 01, 2022 and had been its Whole-Time Director since January 15, 2005 until April 01, 2022. He...

이사회 구성원

이름	위치	테뉴어	보상	소유권
Harsha Agarwal	MD & Vice Chairman	19.5yrs	₹61.81m	0.13% ₹ 403.7m
Mohan Goenka	Vice Chairman & Whole Time Director	19.5yrs	₹61.81m	0.26% ₹ 847.9m
Sushil Goenka	Whole-Time Director	29.2yrs	₹18.09m	0.34% ₹ 1.1b
Prashant Goenka	Whole-Time Director	10.5yrs	₹15.94m	0.099% ₹ 318.9m
Priti Sureka	Whole Time Director	14.5yrs	₹15.94m	3.78% ₹ 12.1b
Radhe Goenka	Founder & Non-Executive Chairman	30.2yrs	₹73.42m	0.54% ₹ 1.7b
Radhe Agarwal	Founder & Chairman Emeritus	30.2yrs	₹73.42m	0.084% ₹ 270.9m
Chandra Dhanuka	Non-Executive Independent Director	6.9yrs	₹920.00k	데이터 없음
Aditya Agarwal	Non-Executive Director	19.5yrs	₹500.00k	0.25% ₹ 798.9m
Debabrata Sarkar	Non-Executive Independent Director	5.4yrs	₹985.00k	데이터 없음
Mamta Binani	Independent Director	2.8yrs	₹900.00k	데이터 없음
Anand Rathi	Independent Director	1.9yrs	₹655.00k	데이터 없음

17.0yrs

평균 재임 기간

60yo

평균 연령

경험이 풍부한 이사회: 531162 의 이사회는 노련하고 경험이 있습니다(평균 재직 기간 16.9 년).

Emami 관리

관리 기준 확인 1/4

주요 정보

최근 관리 업데이트

Emami Limited Announces Change in Management

Emami Limited Announces Changes to the Senior Management Personnel

Insider recently bought ₹1.0m worth of stock

Emami Limited Announces Cessation of Mr. Vinod Rao, President-CCD, Personnel of Senior Management Effective from the Closing Hours of July 31, 2023

Emami Limited, Annual General Meeting, Aug 23, 2023

Emami Limited Approves Executive Changes

Recent updates

Investor sentiment improves as stock rises 34%

Price target increased by 8.2% to ₹613

Full year 2024 earnings released: EPS: ₹16.55 (vs ₹14.50 in FY 2023)

Emami Limited (BSE:531162) signed a share purchase agreement to acquire 4.64% stake in Brillare Science Pvt. Ltd. from founder and other shareholders of Brillare Science Pvt. Ltd.

Dividend of ₹4.00 announced

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Emami Limited Approves Second Interim Dividend for the Financial Year 2023-24

Investor sentiment improves as stock rises 16%

Emami Limited Declares Interim Dividend for the Financial Year 2023-24

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Emami Limited (BSE:531162) completed the acquisition of 26% stake in Axiom Ayurveda Private Limited

Emami Limited (BSE:531162) entered into definitive agreement to acquire 26% stake in Axiom Ayurveda Private Limited.

Emami Limited Announces Change in Management

Manipal Health Enterprises Pvt Ltd acquired 84% stake in AMRI Hospitals Ltd. from Emami Limited (BSE:531162).

Manipal Health Enterprises Pvt Ltd acquired 84% stake in AMRI Hospitals Ltd. from Emami Limited (BSE:531162).

Emami Limited Announces Changes to the Senior Management Personnel

Insider recently bought ₹1.0m worth of stock

Emami May Seal AMRI Sale to Manipal Group This Month

Price target increased by 7.6% to ₹517

Emami Limited Announces Cessation of Mr. Vinod Rao, President-CCD, Personnel of Senior Management Effective from the Closing Hours of July 31, 2023

Full year 2023 earnings: EPS misses analyst expectations

Emami Limited to Report Q4, 2024 Results on May 30, 2024

Emami Limited Proposes Two Interim Dividends for the Financial Year 2022-23

Emami Limited, Annual General Meeting, Aug 23, 2023

Emami Limited to Report Q1, 2024 Results on Aug 07, 2023

Emami Limited Approves Executive Changes

Full year 2023 earnings: EPS misses analyst expectations

Price target decreased by 7.3% to ₹510

Third quarter 2023 earnings: EPS exceeds analyst expectations

Emami Limited Declares Second Interim Dividend for the Financial Year 2022-23

Emami Limited to Report Q3, 2023 Results on Feb 03, 2023

Max Healthcare Reportedly Eyeing AMRI Hospitals

Second quarter 2023 earnings: EPS exceeds analyst expectations

Second quarter 2023 earnings: EPS exceeds analyst expectations

Emami Limited Declares Interim Dividend for the Financial Year 2022-23

Emami Limited to Report Q2, 2023 Results on Nov 11, 2022

Emami Limited, Annual General Meeting, Sep 09, 2022

Consensus forecasts updated

First quarter 2023 earnings released: EPS: ₹1.67 (vs ₹1.75 in 1Q 2022)

Emami Limited (BSE:531162) acquired 30% stake in Cannis Lupus Services India Private Limited.

Emami Limited to Report Q1, 2023 Results on Jul 29, 2022

Full year 2022 earnings: EPS exceeds analyst expectations

Emami Limited Announces Executive Changes

Emami Limited (BSE:531162) acquired 19% equity stake in Tru Native F&B Private Limited.

Emami Limited (BSE:531162) announces an Equity Buyback for INR 1,620 million worth of its shares.

Emami Ltd Restructures Its Board, Effective April 1, 2022

Third quarter 2022 earnings: EPS exceeds analyst expectations

Emami Limited Announces Declaration of Second Interim Dividend

Second quarter 2022 earnings released: EPS ₹4.17 (vs ₹2.66 in 2Q 2021)

Upcoming dividend of ₹4.00 per share

Non-Executive Independent Director Rama Bijapurkar has left the company

First quarter 2022 earnings released: EPS ₹1.75 (vs ₹0.88 in 1Q 2021)

Price target increased to ₹619

Full year 2021 earnings released: EPS ₹10.23 (vs ₹6.67 in FY 2020)

New 90-day high: ₹502

Analysts increase EPS estimates to ₹9.78

Third quarter 2021 earnings released: EPS ₹4.70 (vs ₹3.18 in 3Q 2020)

Revenue and earnings beat expectations

Price target raised to ₹510

New 90-day high: ₹451

New 90-day high: ₹401

Emami Limited to Hit the Indian Market with Its Newest Offering ­Emasol-A Complete Range for Home Hygiene Products

Price target raised to ₹382

Emami Limited to Report Q2, 2021 Results on Nov 14, 2020

Emami Limited to Report Q1, 2021 Results on Aug 07, 2020

Emami Limited Announces Suspension of the Operation At the Manufacturing Units

CEO 보상 분석

CEO

테뉴어

Emami Limited to Hit the Indian Market with Its Newest Offering Emasol-A Complete Range for Home Hygiene Products